NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
Berman
E
E
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Clift
R A
RA
Copelan
E A
EA
Emanuel
P D
PD
Erba
H P
HP
Glenn
M J
MJ
Greenberg
P L
PL
Jones
R J
RJ
O'Brien
S
S
Saba
H I
HI
Schilder
R
R
Snyder
D S
DS
Soiffer
R J
RJ
Tallman
M S
MS
Wetzler
M
M
Ravandi-Kashani
F
F
Kantarjian
H
H
Talpaz
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy; D008991:Monitoring, Physiologic; D012008:Recurrence; D014184:Transplantation, Homologous; D014481:United States
D000970:Antineoplastic Agents; D016898:Interferon-alpha